{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T11:18:31Z","timestamp":1763032711880,"version":"3.45.0"},"reference-count":57,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK123205"],"award-info":[{"award-number":["R01DK123205"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA048172"],"award-info":[{"award-number":["K01DA048172"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["HIS\u20101507\u201031640"],"award-info":[{"award-number":["HIS\u20101507\u201031640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Objective:To identify specialty\u2010specific influences in administering HCV treatment among primary care, gastroenterology\/hepatology, infectious diseases, and addiction specialties, and strategies to potentially eliminate HCV. Study Setting and Design:Qualitative study using remote interviews with healthcare providers in New York and Alabama who treated or screened patients for HCV, purposefully sampling for specialty, clinical setting, and HCV treatment experience. Data sources and Analytic Sample: Interviews occurred 9\/2021\u20138\/2022. Transcripts were analyzed using a hybrid inductive\u2010deductive approach; a content analysis identified codes arising uniquely within specialties. Results: Thirty\u2010six providers were interviewed: primary care (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20099), addiction medicine (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200912), infectious diseases (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20099), and gastroenterology\/hepatology (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096). Distinct challenges and facilitators emerged across specialties. Primary care and addiction providers similarly emphasized the convenience and usual practice of referring patients to specialists for HCV treatment, while infectious disease and gastroenterology noted challenges with patients not completing the referrals. Primary care providers expressed wanting training and peer support related to treatment provision. Addiction providers described structural barriers, such as lacking on\u2010site phlebotomy services and patients' competing health concern prioritization, but highlighted strategies to improve treatment access, including trust\u2010building. Infectious disease providers highlighted using patient navigators to overcome logistical barriers, while gastroenterologists emphasized collaborative relationships, particularly with addiction specialists. Specialty\u2010specific opportunities emerged regarding training, collaboration, navigation, and infrastructure. Conclusions:Eliminating HCV requires addressing specialty\u2010specific concerns for providers managing HCV. Potential opportunities include dissemination of specialty\u2010tailored training, facilitating interdisciplinary care and desired cross\u2010specialty collaborations, and overcoming unique infrastructural needs. Future research should evaluate implementation strategies addressing these specialty\u2010specific needs.\n                  <\/jats:p>","DOI":"10.1111\/jvh.70093","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:54:01Z","timestamp":1759514041000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-4175","authenticated-orcid":false,"given":"Christopher J.","family":"Gonzalez","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence N.","family":"Perez\u2010Mejia","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-2839","authenticated-orcid":false,"given":"Shashi N.","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7686-1526","authenticated-orcid":false,"given":"Jeff","family":"Niederdeppe","sequence":"additional","affiliation":[{"name":"Cornell Jeb E. Brooks School of Public Policy and Department of Communication Cornell University  Ithaca New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences University at Buffalo  Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoi","family":"Papalamprakopoulou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences University at Buffalo  Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Talal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences University at Buffalo  Buffalo New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey R.","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases University of Alabama at Birmingham  Birmingham Alabama USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Medicine Miller School of Medicine  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin F.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Wethington","sequence":"additional","affiliation":[{"name":"Department of Psychology, College of Human Ecology Cornell University  Ithaca New York USA"},{"name":"Department of Sociology, College of Arts and Sciences Cornell University  Ithaca New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27978"},{"key":"e_1_2_10_3_1","unstructured":"Office of Infectious Disease and HIV\/AIDS Policy \u201cViral Hepatitis in the United States: Data and Trends \u201d(2016)."},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325\u2010020\u201001535\u20103"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000001573"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010017\u20104280\u2010y"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.05.010"},{"key":"e_1_2_10_8_1","unstructured":"U.S. Department of Health and Human Services \u201cViral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021\u20132025) \u201d."},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.01.010"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010024\u201008807\u20106"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7226a3"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.7448\/ias.20.1.22146"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.01.017"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz694"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954\u2010024\u201001057\u2010z"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010022\u201007860\u20103"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010016\u20104097\u20102"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010017\u20104608\u20109"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa207"},{"key":"e_1_2_10_20_1","unstructured":"R.Franco O.Massoud J.Galbraith et\u00a0al. \u201cPreliminary Experience of the Alabama Coalition for Testing Interventions and Engagement in Hepatitis C Care (ACTIVE\u2010C) \u201d."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106632"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2452"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20100009.2005.00428.x"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.4135\/9781526435477"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102288\u201013\u2010117"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012\u2010022\u201001245\u20100"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1037\/13620-004"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/sw\/46.2.125"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.2196\/53049"},{"key":"e_1_2_10_31_1","unstructured":"Empire Liver Foundation \u201cHepatitis Clinical Provider Training \u201d(2024)."},{"key":"e_1_2_10_32_1","unstructured":"American Association for the Study of Liver Diseases The Infectious Diseases Society of America \u201cAASLD Simplified HCV treatment for treatment\u2010naive adults without cirrhosis \u201dhttps:\/\/www.hcvguidelines.org\/sites\/default\/files\/full\u2010guidance\u2010pdf\/AASLD\u2010IDSA_HCV\u2010Guidance_TxN\u2010Simplified\u2010Tx\u2010No\u2010Cirr_e.pdf."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2024.06.011"},{"key":"e_1_2_10_34_1","unstructured":"University of Washington Centers for Disease Control and Prevention Infectious Diseases Education & Assessment The University of Alabama at Birmingham \u201cHepatitis C Online \u201dhttps:\/\/www.hepatitisc.uw.edu\/."},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32834bcb36"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15071413"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.08.006"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2019.1587353"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13877"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.01.037"},{"key":"e_1_2_10_42_1","unstructured":"Centers for Disease Control and Prevention \u201cSafe Injection Practices and Your Health \u201d(2024)."},{"key":"e_1_2_10_43_1","unstructured":"Centers for Disease Control and Prevention \u201cSafe Injection Practices to Prevent Transmission of Infections to Patients \u201d(2024)."},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15191"},{"issue":"11","key":"e_1_2_10_45_1","first-page":"628","article-title":"Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real\u2010World Examples","volume":"18","author":"Finbr\u00e5ten A. K.","year":"2022","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.4.329"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw806"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010015\u20103209\u20106"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.15523"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.2196\/48135"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000001328"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa574"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.05.023"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722\u2010023\u201000363\u20104"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac688"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108421"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2055\u20106640(20)30254\u20105"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.08.004"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T11:14:21Z","timestamp":1763032461000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.70093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/jvh.70093"],"URL":"https:\/\/doi.org\/10.1111\/jvh.70093","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"type":"print","value":"1352-0504"},{"type":"electronic","value":"1365-2893"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70093"}}